Видео ютуба по тегу Kcnt1 Epilepsy

Paddy's story - KCNT1-related epilepsy
Paddy's story - KCNT1-related epilepsy
Newly Anticipated ASO Therapeutic for a Genetic Target: Biogen
Newly Anticipated ASO Therapeutic for a Genetic Target: Biogen
Open Book with the KCNT1 Epilepsy Foundation
Open Book with the KCNT1 Epilepsy Foundation
KCNT1 Epilepsy Foundation Overview Nov 2024 - Ali Rosenberg, PhD
KCNT1 Epilepsy Foundation Overview Nov 2024 - Ali Rosenberg, PhD
Unveiling Mysteries: Questions About KCNT1 Pediatric Epilepsy | Dr. Matthew Weston Shares Insights
Unveiling Mysteries: Questions About KCNT1 Pediatric Epilepsy | Dr. Matthew Weston Shares Insights
Empowering Families on the Journey with KCNT1-Related Epilepsy: Insights from Dr. David Bearden
Empowering Families on the Journey with KCNT1-Related Epilepsy: Insights from Dr. David Bearden
Rare childhood epilepsy - symptoms, diagnosis and genetic causes | Dr Amy McTague
Rare childhood epilepsy - symptoms, diagnosis and genetic causes | Dr Amy McTague
Ryan's Story: Gene Discoveries in Epilepsy Treatment
Ryan's Story: Gene Discoveries in Epilepsy Treatment
Andrew's Story: Fighting KCNT1-related Pediatric Epilepsy
Andrew's Story: Fighting KCNT1-related Pediatric Epilepsy
Case study: fluoxetine and KCNT1-related epilepsy
Case study: fluoxetine and KCNT1-related epilepsy
Justin’s Journey | Rare Disease | KCNT1 Epilepsy Foundation & Citizen Health
Justin’s Journey | Rare Disease | KCNT1 Epilepsy Foundation & Citizen Health
Reduction of KCNT1 is therapeutic in mouse models of SNC1A and SCN8A epilepsy
Reduction of KCNT1 is therapeutic in mouse models of SNC1A and SCN8A epilepsy
@emmanuelconquersepilepsy2910 KCNT1 seizure
@emmanuelconquersepilepsy2910 KCNT1 seizure
KCNT1 Epilepsy @EmmanuelConquersEpilepsy
KCNT1 Epilepsy @EmmanuelConquersEpilepsy
KCNT1 Epilepsy seizure changes
KCNT1 Epilepsy seizure changes
Patient-derived 2D and 3D Models of KCNT1 related Epilepsy
Patient-derived 2D and 3D Models of KCNT1 related Epilepsy
Actio Biosciences & KCNT1 Epilepsy Foundation: Bringing Meaningful Therapies from One to Many
Actio Biosciences & KCNT1 Epilepsy Foundation: Bringing Meaningful Therapies from One to Many